Nebenwirkungen · MabThera
MabThera 100 mg concentrate for solution for infusion MabThera 500 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 25
HOS-087605 · Präparat HOS-083527
MedDRA System Organ Class Very Common Common Not known Infections and infestations urinary tract infection, serious viral infection1,2, bronchitis, enteroviral herpes zoster, meningoencephalitis1 nasopharyngitis Blood and lymphatic system thrombocytopenia disorders Immune system disorders cytokine release syndrome Metabolism and nutrition hyperkalaemia disorders Psychiatric disorders insomnia Nervous system disorders dizziness, tremor Vascular disorders hypertension flushing Respiratory, thoracic and cough, nasal congestion mediastinal disorders dyspnoea, epistaxis Gastrointestinal disorders diarrhoea dyspepsia, constipation Skin and subcutaneous tissue acne disorders Musculoskeletal and muscle spasms, muscle weakness, connective tissue disorders arthralgia, musculoskeletal pain, back pain pain in extremities General disorders and oedema peripheral administration site conditions Investigations decreased haemoglobin 1 Observed during post-marketing surveillance. 2 See also section infections below.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-06T15:15:00Z · SHA-256 595c4e1a263e9a34be8b62842a5fc67f95f6a1b1f2a250341444a2960c6c3962 · Passage d6ddf2e8407c462b11581ef47a1951eb29db3b7e02a2572984727b3b0487d200 · Zeichen 39991–42072 im Abschnitt